Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recurrent copy number variations in human induced pluripotent stem cells.

Literature DB >> 21654665

Recurrent copy number variations in human induced pluripotent stem cells.

Kristen Martins-Taylor, Benjamin S Nisler, Seth M Taapken, Tiwanna Compton, Leann Crandall, Karen Dyer Montgomery, Marc Lalande, Ren-He Xu.

Abstract

Entities: Species

Mesh：

Year: 2011 PMID： 21654665 DOI： 10.1038/nbt.1890

Source DB: PubMed Journal: Nat Biotechnol ISSN： 1087-0156 Impact factor: 54.908

× No keyword cloud information.

13 in total

1. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells.

Authors: Jonathan S Draper; Kath Smith; Paul Gokhale; Harry D Moore; Edna Maltby; Julie Johnson; Lorraine Meisner; Thomas P Zwaka; James A Thomson; Peter W Andrews
Journal: Nat Biotechnol Date: 2003-12-07 Impact factor: 54.908

2. Preserving the genetic integrity of human embryonic stem cells.

Authors: Maisam M Mitalipova; Raj R Rao; Deborah M Hoyer; Julie A Johnson; Lorraine F Meisner; Karen L Jones; Stephen Dalton; Steven L Stice
Journal: Nat Biotechnol Date: 2005-01 Impact factor: 54.908

3. Recurrent chromosomal abnormalities in human embryonic stem cells.

Authors: Claudia Spits; Ileana Mateizel; Mieke Geens; Afroditi Mertzanidou; Catherine Staessen; Yves Vandeskelde; Josiane Van der Elst; Inge Liebaers; Karen Sermon
Journal: Nat Biotechnol Date: 2008-11-23 Impact factor: 54.908

4. Copy number variation and selection during reprogramming to pluripotency.

Authors: Samer M Hussein; Nizar N Batada; Sanna Vuoristo; Reagan W Ching; Reija Autio; Elisa Närvä; Siemon Ng; Michel Sourour; Riikka Hämäläinen; Cia Olsson; Karolina Lundin; Milla Mikkola; Ras Trokovic; Michael Peitz; Oliver Brüstle; David P Bazett-Jones; Kari Alitalo; Riitta Lahesmaa; Andras Nagy; Timo Otonkoski
Journal: Nature Date: 2011-03-03 Impact factor: 49.962

5. High resolution array-CGH characterization of human stem cells using a stem cell focused microarray.

Authors: Aaron M Elliott; Kristi A Hohenstein Elliott; Anja Kammesheidt
Journal: Mol Biotechnol Date: 2010-11 Impact factor: 2.695

6. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

Authors: Louise C Laurent; Igor Ulitsky; Ileana Slavin; Ha Tran; Andrew Schork; Robert Morey; Candace Lynch; Julie V Harness; Sunray Lee; Maria J Barrero; Sherman Ku; Marina Martynova; Ruslan Semechkin; Vasiliy Galat; Joel Gottesfeld; Juan Carlos Izpisua Belmonte; Chuck Murry; Hans S Keirstead; Hyun-Sook Park; Uli Schmidt; Andrew L Laslett; Franz-Josef Muller; Caroline M Nievergelt; Ron Shamir; Jeanne F Loring
Journal: Cell Stem Cell Date: 2011-01-07 Impact factor: 24.633

7. Reprogramming of human somatic cells to pluripotency with defined factors.

Authors: In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal: Nature Date: 2007-12-23 Impact factor: 49.962

8. Induced pluripotent stem cell lines derived from human somatic cells.

Authors: Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal: Science Date: 2007-11-20 Impact factor: 47.728

9. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21.

Authors: Nathalie Lefort; Maxime Feyeux; Cécile Bas; Olivier Féraud; Annelise Bennaceur-Griscelli; Gerard Tachdjian; Marc Peschanski; Anselme L Perrier
Journal: Nat Biotechnol Date: 2008-11-23 Impact factor: 54.908

10. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.

Authors: Ryan Lister; Mattia Pelizzola; Yasuyuki S Kida; R David Hawkins; Joseph R Nery; Gary Hon; Jessica Antosiewicz-Bourget; Ronan O'Malley; Rosa Castanon; Sarit Klugman; Michael Downes; Ruth Yu; Ron Stewart; Bing Ren; James A Thomson; Ronald M Evans; Joseph R Ecker
Journal: Nature Date: 2011-02-02 Impact factor: 49.962

96 in total

1. Non-viral iPSCs: a safe way for therapy?

Authors: Weiqi Zhang; Di Guan; Jing Qu; Weizhou Zhang; Guang-Hui Liu
Journal: Protein Cell Date: 2012-04 Impact factor: 14.870

Review 2. Cellular reprogramming: a novel tool for investigating autism spectrum disorders.

Authors: Kun-Yong Kim; Yong Wook Jung; Gareth J Sullivan; Leeyup Chung; In-Hyun Park
Journal: Trends Mol Med Date: 2012-07-06 Impact factor: 11.951

3. The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming.

Authors: Junjie Lu; Hu Li; Ming Hu; Takayo Sasaki; Anna Baccei; David M Gilbert; Jun S Liu; James J Collins; Paul H Lerou
Journal: Cell Rep Date: 2014-03-27 Impact factor: 9.423

Recurrent copy number variations in human induced pluripotent stem cells.

1. Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells.

2. Preserving the genetic integrity of human embryonic stem cells.

3. Recurrent chromosomal abnormalities in human embryonic stem cells.

4. Copy number variation and selection during reprogramming to pluripotency.

5. High resolution array-CGH characterization of human stem cells using a stem cell focused microarray.

6. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture.

7. Reprogramming of human somatic cells to pluripotency with defined factors.

8. Induced pluripotent stem cell lines derived from human somatic cells.

9. Human embryonic stem cells reveal recurrent genomic instability at 20q11.21.

10. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.

1. Non-viral iPSCs: a safe way for therapy?

Review 2. Cellular reprogramming: a novel tool for investigating autism spectrum disorders.

3. The distribution of genomic variations in human iPSCs is related to replication-timing reorganization during reprogramming.

Review 4. Preclinical studies for induced pluripotent stem cell-based therapeutics.

Review 5. The potential for immunogenicity of autologous induced pluripotent stem cell-derived therapies.

6. iPSC-derived forebrain neurons from FXS individuals show defects in initial neurite outgrowth.

Review 7. Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Review 8. Assessing the risks of genotoxicity in the therapeutic development of induced pluripotent stem cells.

9. Functional in vivo and in vitro effects of 20q11.21 genetic aberrations on hPSC differentiation.

10. Passage number is a major contributor to genomic structural variations in mouse iPSCs.